Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
General information only, not medical or infection-control advice. Follow your facility’s own policies and the manufacturer’s instructions.
Short answer
“Bunny suit” is informal hospital slang for a full-body coverall worn over or instead of ordinary clothing. In practice it names two different things: a nonshedding cleanroom garment worn to protect sterile products and processes from the wearer, and a coverall used inside an isolation-precaution ensemble to protect the wearer. FDA and CDC guidance describe different purposes, so confirm which one is meant before specifying or approving anything.
Definition and scope: one slang term, two uses
Neither FDA nor CDC calls the garment a “bunny suit”; both use the formal words “gown” and “coverall”. The slang is a convenience, and it is why two groups of staff can use the same phrase and mean different equipment. For the cleanroom meaning, see our guides to the cleanroom gown and cleanroom classifications. For the isolation meaning, see the PPE donning and doffing sequence. For fabric and reuse questions, see reusable vs disposable scrubs and coveralls.
How each use works in practice
Aseptic and cleanroom garments (FDA)
FDA’s guidance for sterile drug products made by aseptic processing says the gown “should provide a barrier between the body and exposed sterilized materials and prevent contamination from particles generated by, and microorganisms shed from, the body.” It recommends gowns that are sterilized and nonshedding and that cover the skin and hair, with face-masks, hoods, beard or moustache covers, protective goggles and elastic gloves given as common elements. It also says written procedures should detail how each component is donned aseptically, that components should overlap to create an adequate barrier (for example gloves over sleeves), and that a torn or defective element should be changed immediately. The guidance is nonbinding and dates from October 2004. For the full procedure, see cleanroom gowning procedure.
Isolation coveralls (CDC)
CDC’s personal protective equipment guidance for viral hemorrhagic fevers (page dated June 17, 2026) lets a facility choose a respirator, either an N95 or a powered air-purifying respirator (PAPR), and a body covering, either a coverall or a gown. Its donning procedure assumes the facility chose an N95 and a coverall. CDC states that providers must receive training and demonstrate competency in all VHF-related infection control practices, and it describes a trained observer, a dedicated person whose sole responsibility is ensuring adherence to the whole donning procedure, who reads each checklist step aloud, confirms it and documents it. Step-by-step sequences belong in your facility’s training, not on this page.
Cleanroom coverall versus isolation coverall
| Question | Aseptic / cleanroom (FDA) | Isolation ensemble (CDC) |
|---|---|---|
| What it is protecting | Exposed sterilized materials, from particles and microorganisms shed by the body | The health care provider, as part of VHF PPE |
| Body covering | Gown that is sterilized and nonshedding and covers skin and hair | Coverall or gown, a facility choice, paired with N95 or PAPR |
| Procedure requirement | Written procedures for donning each component aseptically | Donning procedure with a trained observer and checklist |
| Observer role | Not described in the FDA guidance | Trained observer reads and documents each checklist step |
| People requirement | Gowning qualification and periodic requalification | Training and demonstrated competency |
Where it matters for labs, clinics and supply decisions
The practical risk is ordering or approving against the wrong meaning. A checklist of questions drawn from the FDA and CDC guidance, to ask internally and of any supplier, follows.
- Is the intended use an aseptic barrier or an isolation precaution? FDA and CDC address these as separate purposes.
- Which elements are in the ensemble (coverall, hood, mask, goggles, gloves, respirator)? FDA lists gown elements; CDC pairs a coverall or gown with N95 or PAPR.
- For aseptic use, is the garment sterilized and nonshedding, and does it cover skin and hair?
- Is there a written donning procedure, and do the components overlap to form a barrier?
- What is the rule for replacing a torn or defective element?
- For aseptic use, how is gowning qualified? FDA says assessment should include microbiological surface sampling of several locations on a gown (glove fingers, facemask, forearm, chest), with periodic requalification and written retraining procedures.
- For isolation use, who is trained, how is competency shown, and who acts as the trained observer?
Common misunderstandings
- “A bunny suit is one product.” The phrase covers at least two purposes, which FDA and CDC describe separately.
- “A cleanroom coverall is isolation PPE.” The FDA guidance addresses protecting sterile product from the wearer; the CDC guidance addresses a VHF PPE ensemble. Neither says one substitutes for the other.
- “The suit alone is the control.” Both agencies pair the garment with procedures and people: written donning methods and qualification in one, training, competency and an observer in the other.
FAQ
What is a bunny suit in a hospital?
Slang for a full-body coverall. Depending on the department it means a cleanroom garment that limits shedding from the wearer, or a coverall used in an isolation PPE ensemble.
Is a bunny suit the same as a surgical gown?
Neither FDA nor CDC equates them. Our surgical gown guide covers that product separately.
Who decides whether a coverall or a gown is used for isolation?
For the CDC VHF guidance, the facility chooses between a coverall and a gown, each paired with an N95 or PAPR.
Sources
- U.S. FDA, Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing, Current Good Manufacturing Practice (October 2004, nonbinding). Checked 2026-11-02.
- CDC, Guidance for Personal Protective Equipment (PPE), viral hemorrhagic fevers, health care providers (page dated June 17, 2026). Checked 2026-11-02.







